The Discounted Cash Flow (DCF) valuation of ImmunoGen Inc (IMGN) is (34.09) USD. With the latest stock price at 31.23 USD, the upside of ImmunoGen Inc based on DCF is -209.1%.
Based on the latest price of 31.23 USD and our DCF valuation, ImmunoGen Inc (IMGN) is a sell. selling IMGN stocks now will result in a potential gain of 209.1%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.8% - 9.5% | 8.2% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (78.44) - (21.70) | (34.09) |
| Upside | -351.2% - -169.5% | -209.1% |